home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

57.85 -0.34 (-0.58%)

Streaming Delayed Price Updated: 11:17 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

34 35 Next >

Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again ↗

August 30, 2023

The famous growth investor has been making some interesting stock moves lately.

Via The Motley Fool

3 Surprisingly Underrated Stocks to Buy Right Now ↗

August 26, 2023

These stocks deserve more respect than they're getting.

Via The Motley Fool

Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge ↗

August 24, 2023

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks ↗

August 24, 2023

The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases.

Via The Motley Fool

3 Clever Tricks to Find Winning Biotech Stocks ↗

August 24, 2023

You'll need to dig into company details, but the effort is worthwhile.

Via The Motley Fool

What 13 Analyst Ratings Have To Say About CRISPR Therapeutics ↗

August 14, 2023

Via Benzinga

Why CRISPR Therapeutics Stock Is Jumping Today ↗

August 08, 2023

Analysts continue to like this gene-editing stock.

Via The Motley Fool

1 No-Brainer Cathie Wood Stock to Buy Hand Over Fist in August ↗

August 02, 2023

Crispr Therapeutics could be incredibly undervalued right now.

Via The Motley Fool

Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M ↗

August 22, 2023

Via Benzinga

Topics Earnings

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation ↗

August 22, 2023

Helping save and improve patients' lives in novel ways can be a lucrative activity.

Via The Motley Fool

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead ↗

August 21, 2023

Via Benzinga

Stocks to Watch This Week’s Top 7 Wall Street Upgrades ↗

August 21, 2023

With the market printing some red ink recently, investors may take greater confidence in the top Wall Street upgrades this week.

Via InvestorPlace

The Latest Analyst Ratings for CRISPR Therapeutics ↗

July 25, 2023

Via Benzinga

Gene Therapy Breakthroughs On The Horizon ↗

August 21, 2023

Vertex Pharmaceuticals and CRISPR Therapeutics, alongside bluebird bio, are penning a new chapter in the story of gene therapy for sickle cell disease.

Via Talk Markets

3 Green Flags for Biotech Stocks in 2023 and Beyond ↗

August 19, 2023

The industry is changing rapidly, and for the better.

Via The Motley Fool

The 3 Most Undervalued Cathie Wood Stocks to Buy Now: August 2023 ↗

August 16, 2023

Even if Cathie Wood stocks in ARK fell from grace, these three portfolio picks remain undervalued and ideal investments.

Via InvestorPlace

Missed Out on CRISPR Therapeutics? My Best Biotech Stock to Buy and Hold ↗

August 14, 2023

CRISPR Therapeutics is an intriguing biotech stock to consider now.

Via The Motley Fool

3 Reasons to Buy CRISPR Therapeutics Stock, and 1 Reason to Sell ↗

August 12, 2023

This company is in a critical period, and it could soon grow significantly.

Via The Motley Fool

Ready to Buy the Dip? CRISPR Therapeutics Stock Is a Smart Buy ↗

August 11, 2023

Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential.

Via The Motley Fool

Cathie Wood Buys Roblox, Palantir Dips — Ark Invest Seizes Buying Opportunities Following Earnings Reports ↗

August 09, 2023

Via Benzinga

The 3 Best Biotech Stocks to Buy in August ↗

August 09, 2023

Even as healthcare stocks suffer from post-pandemic fatigue, these three of the best biotech stocks to buy and ride the wave of good news.

Via InvestorPlace

2 Supercharged Growth Stocks That Could Make You Richer ↗

August 09, 2023

These two biotechs are poised for a sustained period of growth.

Via The Motley Fool

2 Great Stocks Under $100 to Buy and Hold for 10 Years ↗

August 09, 2023

Neither has performed well over the past year, but investors would do well to focus on the longer term.

Via The Motley Fool

Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗

August 08, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to...

Via Benzinga

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

3 Biotech Stocks That Analysts Are Drooling Over ↗

August 07, 2023

With the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time.

Via InvestorPlace

3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now ↗

August 02, 2023

Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.

Via InvestorPlace

Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline ↗

August 02, 2023

Vertex Pharmaceuticals Inc's (NASDAQ: VRTX) Q2 sales increased 14% to $2.49 billion, beating the consensus of $2.41 bill

Via Benzinga

3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗

July 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Via InvestorPlace

These 2 Stocks Are Heading for a Big Moment. Time to Buy? ↗

July 31, 2023

Both stocks have climbed in the double digits this year.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com